{
    "2021-12-28": [
        [
            {
                "time": "2021-12-28",
                "original_text": "华东医药：子公司全资收购华昌高科 开拓工业微生物新领域",
                "features": {
                    "keywords": [
                        "华东医药",
                        "全资收购",
                        "华昌高科",
                        "工业微生物"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-28",
                "original_text": "加快工业微生物技术优势全球化产业发展 华东医药全资收购华昌高科",
                "features": {
                    "keywords": [
                        "工业微生物",
                        "全球化",
                        "华东医药",
                        "全资收购"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-28",
                "original_text": "华东医药(000963.SZ)：子公司中美华东拟收购破产重整后的华昌高科100%股权 关联方问题",
                "features": {
                    "keywords": [
                        "华东医药",
                        "中美华东",
                        "破产重整",
                        "华昌高科",
                        "100%股权"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-28",
                "original_text": "华东医药：参与华昌高科破产重整 收购其100%股权 减资破产",
                "features": {
                    "keywords": [
                        "华东医药",
                        "破产重整",
                        "华昌高科",
                        "100%股权",
                        "减资"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-28",
                "original_text": "华东医药今日大宗交易成交36万股，成交价38.7元溢价0.0%",
                "features": {
                    "keywords": [
                        "华东医药",
                        "大宗交易",
                        "36万股",
                        "38.7元",
                        "溢价0.0%"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-28",
                "original_text": "天士力被收智商税？ 首付2.5亿元引入进度落后的FRα ADC",
                "features": {
                    "keywords": [
                        "天士力",
                        "智商税",
                        "2.5亿元",
                        "FRα ADC",
                        "进度落后"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}